Corporate Social Responsibility Report

Overview

The report describes Shanghai Pharmaceuticals' 2019 responsibility performance across its group and subsidiaries. It highlights RMB186.566 billion in annual revenue, continued R&D and access-to-medicine initiatives, and a workforce of 47,778 employees. The report also details targeted poverty alleviation, charitable and community programs, occupational safety, and environmental-management initiatives, including group comprehensive energy consumption of 117,900 tonnes of standard coal. A substantial later section documents the company's realized response to the COVID-19 pandemic, including medicine production, supply logistics, R&D cooperation and donations.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services